thebetterhealthstore.com — Novartis Pharmaceuticals Corp. announced its decision to voluntarily suspend sales of its anti-constipation drug, Zelnorm (tegaserod maleate), at the request of the Food and Drug Administration (FDA). The drug had been on the market for about five years.